Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats
Hepatic fibrosis is one kind of liver diseases with a high mortality rate and incidence. The activation and proliferation of hepatic stellate cells (HSCs) is the most fundamental reason of hepatic fibrosis. There are no specific and effective drug delivery carriers for the treatment of hepatic fibro...
Main Authors: | Wenhao Li, Chuchu Zhou, Yao Fu, Tijia Chen, Xing Liu, Zhirong Zhang, Tao Gong |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | Acta Pharmaceutica Sinica B |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383519300553 |
Similar Items
-
Targeted delivery of BMP4-siRNA to hepatic stellate cells for treatment of liver fibrosis
by: Omar, Refaat
Published: (2015) -
Regulation Of Activated Hepatic Stellate Cytotoxicity By Polyphenolic Compounds And Their Targeting Delivery Using Hyaluronic Acid-polylactic Acid Nanoparticles
by: Liu, Yiting, et al.
Published: (2012) -
Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis
by: Hans-Theo eSchon, et al.
Published: (2016-02-01) -
Bevacizumab attenuates hepatic fibrosis in rats by inhibiting activation of hepatic stellate cells.
by: Yangqing Huang, et al.
Published: (2013-01-01) -
Effect of molecular weight of hyaluronic acid on activated hepatic stellate cells
by: Hsing-Yu Wu, et al.
Published: (2010)